tetradecanoylphorbol acetate has been researched along with dihydroavenanthramide d in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, JH; Hur, H; Hwang, JK; Jung, JY; Jung, SH; Kim, BS; Kim, JM; Kim, JS; Lee, SH; Lee, YR; Noh, EM; Oh, HJ; Park, BH; Park, CS; Park, JW; Youn, HJ | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and dihydroavenanthramide d
Article | Year |
---|---|
Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; ortho-Aminobenzoates; Signal Transduction; Tetradecanoylphorbol Acetate | 2011 |